207 related articles for article (PubMed ID: 33196849)
1. Generation of onco-enhancer enhances chromosomal remodeling and accelerates tumorigenesis.
Chai P; Yu J; Jia R; Wen X; Ding T; Zhang X; Ni H; Jia R; Ge S; Zhang H; Fan X
Nucleic Acids Res; 2020 Dec; 48(21):12135-12150. PubMed ID: 33196849
[TBL] [Abstract][Full Text] [Related]
2. Disruption of a -35 kb Enhancer Impairs CTCF Binding and
Liu Q; Thoms JAI; Nunez AC; Huang Y; Knezevic K; Packham D; Poulos RC; Williams R; Beck D; Hawkins NJ; Ward RL; Wong JWH; Hesson LB; Sloane MA; Pimanda JE
Clin Cancer Res; 2018 Sep; 24(18):4602-4611. PubMed ID: 29898989
[No Abstract] [Full Text] [Related]
3. CANT1 lncRNA Triggers Efficient Therapeutic Efficacy by Correcting Aberrant lncing Cascade in Malignant Uveal Melanoma.
Xing Y; Wen X; Ding X; Fan J; Chai P; Jia R; Ge S; Qian G; Zhang H; Fan X
Mol Ther; 2017 May; 25(5):1209-1221. PubMed ID: 28330694
[TBL] [Abstract][Full Text] [Related]
4. A Cohesin-Mediated Intrachromosomal Loop Drives Oncogenic ROR lncRNA to Accelerate Tumorigenesis.
Fan J; Xu Y; Wen X; Ge S; Jia R; Zhang H; Fan X
Mol Ther; 2019 Dec; 27(12):2182-2194. PubMed ID: 31451355
[TBL] [Abstract][Full Text] [Related]
5. The Tumor-Promoting Role of TRIP4 in Melanoma Progression and its Involvement in Response to BRAF-Targeted Therapy.
Hao J; Xu H; Luo M; Yu W; Chen M; Liao Y; Zhang C; Zhao X; Jiang W; Hou S; Feng X; Zou K; Chen Y; Huang W; Guo W; Kang L; Deng W
J Invest Dermatol; 2018 Jan; 138(1):159-170. PubMed ID: 28899685
[TBL] [Abstract][Full Text] [Related]
6. The CCCTC-binding factor (CTCF)-forkhead box protein M1 axis regulates tumour growth and metastasis in hepatocellular carcinoma.
Zhang B; Zhang Y; Zou X; Chan AW; Zhang R; Lee TK; Liu H; Lau EY; Ho NP; Lai PB; Cheung YS; To KF; Wong HK; Choy KW; Keng VW; Chow LM; Chan KK; Cheng AS; Ko BC
J Pathol; 2017 Dec; 243(4):418-430. PubMed ID: 28862757
[TBL] [Abstract][Full Text] [Related]
7. Enhancer release and retargeting activates disease-susceptibility genes.
Oh S; Shao J; Mitra J; Xiong F; D'Antonio M; Wang R; Garcia-Bassets I; Ma Q; Zhu X; Lee JH; Nair SJ; Yang F; Ohgi K; Frazer KA; Zhang ZD; Li W; Rosenfeld MG
Nature; 2021 Jul; 595(7869):735-740. PubMed ID: 34040254
[TBL] [Abstract][Full Text] [Related]
8. Alteration of CTCF-associated chromatin neighborhood inhibits TAL1-driven oncogenic transcription program and leukemogenesis.
Li Y; Liao Z; Luo H; Benyoucef A; Kang Y; Lai Q; Dovat S; Miller B; Chepelev I; Li Y; Zhao K; Brand M; Huang S
Nucleic Acids Res; 2020 Apr; 48(6):3119-3133. PubMed ID: 32086528
[TBL] [Abstract][Full Text] [Related]
9. miR-367 promotes uveal melanoma cell proliferation and migration by regulating PTEN.
Ling JW; Lu PR; Zhang YB; Jiang S; Zhang ZC
Genet Mol Res; 2017 Aug; 16(3):. PubMed ID: 28829890
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-124a is epigenetically regulated and acts as a tumor suppressor by controlling multiple targets in uveal melanoma.
Chen X; He D; Dong XD; Dong F; Wang J; Wang L; Tang J; Hu DN; Yan D; Tu L
Invest Ophthalmol Vis Sci; 2013 Mar; 54(3):2248-56. PubMed ID: 23404119
[TBL] [Abstract][Full Text] [Related]
11. m
He F; Yu J; Yang J; Wang S; Zhuang A; Shi H; Gu X; Xu X; Chai P; Jia R
Mol Ther; 2021 Jun; 29(6):2121-2133. PubMed ID: 33601055
[TBL] [Abstract][Full Text] [Related]
12. Transcriptional Dysregulation of MYC Reveals Common Enhancer-Docking Mechanism.
Schuijers J; Manteiga JC; Weintraub AS; Day DS; Zamudio AV; Hnisz D; Lee TI; Young RA
Cell Rep; 2018 Apr; 23(2):349-360. PubMed ID: 29641996
[TBL] [Abstract][Full Text] [Related]
13. Rictor regulates the vasculogenic mimicry of melanoma via the AKT-MMP-2/9 pathway.
Liang X; Sun R; Zhao X; Zhang Y; Gu Q; Dong X; Zhang D; Sun J; Sun B
J Cell Mol Med; 2017 Dec; 21(12):3579-3591. PubMed ID: 28699701
[TBL] [Abstract][Full Text] [Related]
14. CTCF mediates the TERT enhancer-promoter interactions in lung cancer cells: identification of a novel enhancer region involved in the regulation of TERT gene.
Eldholm V; Haugen A; Zienolddiny S
Int J Cancer; 2014 May; 134(10):2305-13. PubMed ID: 24174344
[TBL] [Abstract][Full Text] [Related]
15. Status of RASSF1A in uveal melanocytes and melanoma cells.
Calipel A; Abonnet V; Nicole O; Mascarelli F; Coupland SE; Damato B; Mouriaux F
Mol Cancer Res; 2011 Sep; 9(9):1187-98. PubMed ID: 21788308
[TBL] [Abstract][Full Text] [Related]
16. Epigenome editing strategies for the functional annotation of CTCF insulators.
Tarjan DR; Flavahan WA; Bernstein BE
Nat Commun; 2019 Sep; 10(1):4258. PubMed ID: 31534142
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of p14ARF and p16INK4A expression in cutaneous and uveal melanoma.
Venza M; Visalli M; Biondo C; Lentini M; Catalano T; Teti D; Venza I
Biochim Biophys Acta; 2015 Mar; 1849(3):247-56. PubMed ID: 25497382
[TBL] [Abstract][Full Text] [Related]
18. Crizotinib, a c-Met inhibitor, prevents metastasis in a metastatic uveal melanoma model.
Surriga O; Rajasekhar VK; Ambrosini G; Dogan Y; Huang R; Schwartz GK
Mol Cancer Ther; 2013 Dec; 12(12):2817-26. PubMed ID: 24140933
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic control of melanoma cell invasiveness by the stem cell factor SALL4.
Diener J; Baggiolini A; Pernebrink M; Dalcher D; Lerra L; Cheng PF; Varum S; Häusel J; Stierli S; Treier M; Studer L; Basler K; Levesque MP; Dummer R; Santoro R; Cantù C; Sommer L
Nat Commun; 2021 Aug; 12(1):5056. PubMed ID: 34417458
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Alterations and Therapeutic Opportunities in Rare Forms of Melanoma.
Han A; Schug ZT; Aplin AE
Trends Cancer; 2021 Aug; 7(8):671-681. PubMed ID: 34127435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]